FIG
CDAK

Freed Investment Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Freed Investment Group’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$332K Hold
20,328
– – 0.25% 13
2021
Q2 		$377K Hold
20,328
– – 0.29% 12
2021
Q1 		$307K Hold
20,328
– – 0.27% 12
2020
Q4 		$657K Buy
+20,328
New +$269K 0.6% 10

Other funds holding CDAK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Freed Investment Group's CDAK Position: Q3 2021 in Review

Freed Investment Group held its Codiak BioSciences, Inc. Common Stock (CDAK) position steady in Q3 2021 at 20,328 shares worth $332K. The position accounts for 0.25% of the portfolio, ranked #13.

Freed Investment Group first reported a position in CDAK in Q4 2020 and has held it in 4 quarters since. The position peaked at $657K in Q4 2020. 56 funds tracked by Wall St. Rank hold CDAK as of Q3 2021.

  • Freed Investment Group held 20,328 shares of Codiak BioSciences, Inc. Common Stock worth $332K as of Q3 2021.
  • Freed Investment Group left its Codiak BioSciences, Inc. Common Stock share count unchanged in Q3 2021.
  • Codiak BioSciences, Inc. Common Stock made up 0.25% of Freed Investment Group's portfolio in Q3 2021, its #13 holding.
  • Freed Investment Group first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and has held it in 4 quarters since.
  • Freed Investment Group's Codiak BioSciences, Inc. Common Stock position peaked at $657K in Q4 2020.
  • 56 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q3 2021.

Based on Freed Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.